2 results
Approved WMORecruiting
Primary: • Demonstrate superior efficacy (increased progression-free survival [PFS]) of MEK162 vs. physician*s choice of selected chemotherapies (liposomal doxorubicin, paclitaxel and topotecan)Key Secondary: • Demonstrate superior efficacy (…
Approved WMORecruiting
The main objective of this randomised controlled study is to investigate whether patients treated with Arista* AH have less postoperative complaints after inferior turbinate surgery compared to patients treated with non-absorbable Merocel® nasal…